| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_44c713790ce00813da2e6c6d57a29456 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-351
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P1-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P1-16
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P13-12 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P25-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-351
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P1-16
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P13-00 |
| filingDate |
2017-06-19-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_c505bc5823063b08884129ef87365bfc
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_de6351f745a280b44f39df686b1eb9e4
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_29a822f8c6eea7971745286241d94874 |
| publicationDate |
2017-12-29-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
CN-107519161-A |
| titleOfInvention |
Intestinal environment-improvinagent agent |
| abstract |
There is provided that to contain in compound or its pharmaceutics shown in following formula ［ I ］ admissible salt as the intestinal environment-improvinagent agent of active ingredient and the prevention for diseases such as hepatic encephalopathy, uremias or treatment be useful new medicine. |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2021004498-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-110066302-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2019144864-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-110066302-B
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/AU-2019211664-B2 |
| priorityDate |
2016-06-20-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |